$ALKS

$44.44 +$0.81 (1.86%) Close

$ALKS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ALKS Management Team

Mr. David Gaffin

Executive Vice President

Chief Compliance Officer

Chief Legal Officer

Secretary

Age 53

Compensation $4.115M USD

Sex Male

Dr. Craig Hopkinson

Executive Vice President

Research and Development and Chief Medical Officer

Age 57

Compensation $4.344M USD

Sex Male

Mr. Richard Pops

Chairman of the Board

Chief Executive Officer

Age 63

Compensation $10.13M USD

Sex Male

Mr. Joshua Reed

Chief Financial Officer

Senior Vice President

Age 52

Compensation -

Sex Male

Mr. C. Todd Nichols

Senior Vice President

Chief Commercial Officer

Age 56

Compensation $3.319M USD

Sex Male

Mr. Blair Jackson

Chief Operating Officer

Executive Vice President

Age 53

Compensation $4.891M USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. David Gaffin Executive Vice President Chief Compliance Officer Chief Legal Officer Secretary	53	$4.115M USD	Male
Dr. Craig Hopkinson Executive Vice President Research and Development and Chief Medical Officer	57	$4.344M USD	Male
Mr. Richard Pops Chairman of the Board Chief Executive Officer	63	$10.13M USD	Male
Mr. Joshua Reed Chief Financial Officer Senior Vice President	52	-	Male
Mr. C. Todd Nichols Senior Vice President Chief Commercial Officer	56	$3.319M USD	Male
Mr. Blair Jackson Chief Operating Officer Executive Vice President	53	$4.891M USD	Male

Board of Directors

From the proxy statement filed Apr 6, 2026

Directors

serving now

Independent

7 of 8

stated in the proxy

Average tenure

7.1 years

from year joined

CEO also chairs the board

Yes

Richard F. Pops

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Shane M. Cooke	Not stated	2018 8 years	Independent	Audit and Risk · Chair	Prothena Corporation plc (Nasdaq: PRTA)	$484,751
Richard B. Gaynor	Not stated	2019 7 years	Independent	Compensation · Chair	Zai Lab Limited (Nasdaq: ZLAB)	$474,014
Cato T. Laurencin	Not stated	2021 5 years	Independent	Financial Operating	MiMedx Group, Inc. (Nasdaq: MDXG)	Not stated
Nancy S. Lurker	Not stated	2024 2 years	Independent	Compensation Nominating and Corporate Governance · Chair	EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), Collegium Pharmaceutical, Inc. (Nasdaq: COLL)	$476,212
Brian P. McKeon	Not stated	2020 6 years	Independent	Compensation Financial Operating · Chair Nominating and Corporate Governance	Dentsply Sirona Inc. (Nasdaq: XRAY)	$491,333
Richard F. Pops Board chair, CEO	Not stated	2011 15 years	Not independent	Financial Operating	Neurocrine Biosciences, Inc. (Nasdaq: NBIX)	Paid as CEO
Nancy L. Snyderman	Not stated	2016 10 years	Independent	Audit and Risk Financial Operating	None stated	$479,135
Christopher I. Wright	Not stated	2022 4 years	Independent	Audit and Risk Compensation	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 6, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$ALKS Management Team

Mr. David Gaffin

Dr. Craig Hopkinson

Mr. Richard Pops

Mr. Joshua Reed

Mr. C. Todd Nichols

Mr. Blair Jackson

Board of Directors

Related-party transactions

No related-party transactions disclosed